In February 2021, Galderma Aesthetics announced FDA approval of Restylane Defyne for mild to moderate chin receding in adults.1 Defyne is the second hyaluronic acid (HA)…
This month, Shaadi Manouchehri discusses some alternatives to injectables and the importance of providing multiple potential treatment pathways. As part of the process of obtaining valid…
